Adverse events during oral colchicine use: a systematic review and meta-analysis of randomised controlled trials
Abstract Background Colchicine is a widely used drug to treat inflammatory diseases. Due to its long historical use in medicine, controlled clinical trials have been small and there remains some caution with the use of this drug in patients with co-morbidities. The aim of the study is to systematica...
Main Authors: | Sarah Stewart, Kevin Chih Kai Yang, Kate Atkins, Nicola Dalbeth, Philip C. Robinson |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-02-01
|
Series: | Arthritis Research & Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13075-020-2120-7 |
Similar Items
-
COLCHICINE IN RHEUMATOLOGY: YESTERDAY AND TODAY. WILL THERE BE TOMORROW?
by: Z S Alekberova, et al.
Published: (2010-06-01) -
Colchicine for gout
by: M. S. Eliseev, et al.
Published: (2021-08-01) -
Formulation and Evaluation of a Drug-in-Adhesive Patch for Transdermal Delivery of Colchicine
by: Yaran Lei, et al.
Published: (2022-10-01) -
COLCHICINE IS ASSOCIATED WITH LOWER CARDIOVASCULAR MORBIDITY IN GOUT
by: Claudiu Popescu, et al.
Published: (2016-12-01) -
Combined Use of Febuxostat and Colchicine Does Not Increase Acute Hepatotoxicity in Patients with Gout: A Retrospective Study
by: Yoon-Jeong Oh, et al.
Published: (2020-05-01)